Aptinyx Reports Positive Data from Phase 1 Study of Novel NMDA Receptor Modulator, NYX-458, in Healthy Volunteers – Associated Press

Aptinyx Reports Positive Data from Phase 1 Study of Novel NMDA Receptor Modulator, NYX-458, in Healthy Volunteers – Associated Press
Aptinyx Reports Positive Data from Phase 1 Study of Novel NMDA Receptor Modulator, NYX-458, in Healthy Volunteers  Associated PressPress release *content* from Globe Newswire. The AP news staff was not involved in its creation. ... read more
Source: Google NewsPublished on 2019-04-30